Dow Down 0.08% Nasdaq Down 0.35%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
3.85 Down 0.10(2.53%) 4:00PM EST
Prev Close:3.95
Open:3.85
Bid:3.85 x 9500
Ask:3.86 x 10600
1y Target Est:11.50
Beta:3.48
Next Earnings Date:N/A
Day's Range:3.61 - 4.02
52wk Range:3.61 - 11.15
Volume:808,491
Avg Vol (3m):998,653
Market Cap:268.75M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 2.53%268.75M
NKTRUp 1.52%1.51B

Key Statistics

Forward P/E (1 yr):14.26
P/S (ttm):91.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.60
Quarterly EPS Est (Dec-15) :-0.14
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback